OCD Trial, Recruiting (NCT05240924)

OCD Trial, Recruiting NCT05240924 Sponsor: VA Office of Research and Development Condition: OCD

Printed from Voxsanity (voxsanity.com.au) — NCT05240924 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ocd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are a Veteran with a main diagnosis of Obsessive Compulsive Disorder (OCD), either on its own or alongside Post-Traumatic Stress Disorder (PTSD), and you receive care at one of the participating VA medical centers or telehealth hubs (located in Texas, South Carolina, Washington, Oregon, Alaska, New Jersey, New York, northern Pennsylvania, North Carolina, or Virginia)
You are willing to take part in a type of therapy called Exposure and Response Prevention (ERP), which involves gradually facing fears and resisting certain responses (confirm with trial site for full details)

Who may not be able to join:

People with significant memory or thinking problems, or certain conditions that could affect safety, such as current psychosis, mania, an immediate risk of suicide with a plan or intent, or moderate to severe substance use that could interfere with treatment
People who take psychiatric medications but have not been on a stable, unchanged dose for at least 6 weeks before joining the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Terri L. Fletcher, PhD, Michael E. DeBakey VA Medical Center, Houston, TX

Phone: (713) 440-4400

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05240924

Sponsor: VA Office of Research and Development

Phase: Not Applicable

Status: Recruiting

Condition: OCD

Trial contact: (713) 440-4400

More information: https://clinicaltrials.gov/study/NCT05240924

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are a Veteran with a main diagnosis of Obsessive Compulsive Disorder (OCD), either on its own or alongside Post-Traumatic Stress Disorder (PTSD), and you receive care at one of the participating VA medical centers or telehealth hubs (located in Texas, South Carolina, Washington, Oregon, Alaska, New Jersey, New York, northern Pennsylvania, North Carolina, or Virginia)
You are willing to take part in a type of therapy called Exposure and Response Prevention (ERP), which involves gradually facing fears and resisting certain responses (confirm with trial site for full details)

Who may not be able to join:

People with significant memory or thinking problems, or certain conditions that could affect safety, such as current psychosis, mania, an immediate risk of suicide with a plan or intent, or moderate to severe substance use that could interfere with treatment
People who take psychiatric medications but have not been on a stable, unchanged dose for at least 6 weeks before joining the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

VA Office of Research and Development

Registry

ClinicalTrials.gov

Start date

3 October 2022

Est. completion

31 May 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Work and Social Adjustment Scale (WSAS) - Change

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov